Bristol Myers Squibb stock faces a key October 29 results date
AD HOC NEWS
Bristol Myers Squibb (BMY) stock closed at $61.15 on October 2, 2026, 10.9% below its 52-week high, as the company approaches its Q3 2026 earnings release on October 29, 2026. The Q2 revenue was $12.97 billion, exceeding estimates, and analysts have a "Moderate Buy" consensus with an average 12-month price target of $67.06. The upcoming results will be crucial for the stock, balancing new medicine progress against patent expirations.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.